Table 3.
Differences in Delay of Care, Pain Catastrophizing, and Pain Between High and Low Financial Toxicity Cohorts.
| Outcome | Entire cohort (N = 87) | COST score ≤31 (n = 44) | COST score >31 (n = 43) | P value |
|---|---|---|---|---|
| Delayed current visit, No. (%) | 38 (43.7) | 25 (56.8) | 13 (30.2) | <.05 |
| Delayed or skipped any visit in the past year due to cost, No. (%) | 15 (17.2) | 8 (18.2) | 7 (16.3) | 1.00 |
| Skipped recommended test or treatment in the past year due to cost, No. (%) | 12 (13.8) | 8 (18.2) | 4 (9.3) | .37 |
| Pain catastrophizing score | ||||
| Mean (SD) | 12.7 (12.4) | 17.7 (13.5) | 7.6 (8.6) | <.05 |
| Range | 0-49 | 0-49 | 0-31 | |
| Numeric pain score | ||||
| Mean (SD) | 3.4 (2.3) | 4.5 (2.2) | 2.3 (1.8) | <.05 |
| Range | 0-10 | 0-10 | 0-7 | |
Note: COST = COmprehensive Score for financial Toxicity.